Megala Jayaraman
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Megala Jayaraman has a total of 52 co-authors. Here are the top co-authors by number of shared publications:
Diveyaa Sivakumar
School of Dental Sciences, Universiti Sains Malaysia, 16150, Kubang Kerian, Kelantan, Malaysia
6 shared publicationsHanumanth Rao Balaji Raghavendran
Faculty of Clinical Research, Sri Ramachandra Institute of Higher Education and Research, Central Research Facility, Porur, Chennai-600116, India
5 shared publicationsParijat Dutta
Department of Genetic Engineering, Faculty of Engineering and Technology, SRM Institute of Science and Technology, SRM Nagar, Kattankulathur-603203, Chennai, Tamil Nadu, India
5 shared publicationsKayalvizhi Nagarajan
School of Life Sciences, Periyar University
4 shared publicationsKhyati Arora
Department of Genetic Engineering, Faculty of Engineering and Technology, SRM Institute of Science and Technology, SRM Nagar, Kattankulathur-603203, Chennai, Tamil Nadu, India
4 shared publicationsPremkumar Karunakaran
Rajiv Gandhi Govt Gen Hosp, Dept Med Gastroenterol, Chennai, Tamil Nadu, India
4 shared publications
Latest Publications
- 20 April 2026
- Published by Elsevier in Human Immunology
- Vol. 87  (6) , 111741
In silico design of a VacA-based multi-epitope Subunit Vaccine Candidate for immunoprotection against Helicobacter pylori
- 20 April 2026
- Published by Elsevier in Human Immunology
- Vol. 87  (6) , 111741
In silico design of a VacA-based multi-epitope Subunit Vaccine Candidate for immunoprotection against Helicobacter pylori
- 3 April 2026
- Published by Taylor & Francis
- p. 31-48
Probiotic-Based Nanomedicine
- Open Access
- 6 February 2026
- Published by Journal of Pure and Applied Microbiology in Journal of Pure and Applied Microbiology
- Vol. 20  (1) , 312
Exploring the Prevalence of Virulence Genes of Helicobacter pylori and their Association with Gastrointestinal Diseases in South Indian Tamils
Helicobacter pylori, a Gram-negative gastric pathogen and a class I carcinogen harbors key virulence genes such as vacA, cagA, ureC, homB and oipA that contributes to gastrointestinal diseases. The study assessed the prevalence of H. pylori infection and their correlation with virulence genotypes with clinical outcomes in South Indian Tamils. Gastric antral biopsies from 500 patients were assessed for H. pylori prevalence by RUT followed by genomic DNA extraction and PCR. Molecular confirmation employed 16S rRNA, a preliminary marker, with the identification of virulent genes cagA, vacAs1, vacA m1/m2, oipA, ureC, homB are validated by sequencing. H. pylori were confirmed in 491 patients where vacA s1 (71.89%) was correlated with gastritis (OR-1.68;95%; CI: 1.11-2.53; p = 0.013) and pangastritis (OR-4.79;95%; CI: 2.02-11.34; p = 0.0004) while vacA s1/m1 and vacA s1/m2 alleles were found to be 51.53% and 14.26%, respectively. Gastritis was associated with s1/m1 (OR-2.34; 95%CI: 1.29-4.23; p = 0.004), s1/m2 (OR-2.03; 95%CI: 1.04-3.95; p = 0.03) and pangastritis (OR-2.61;95%CI: 0.97-7.02; p = 0.05) was associated with s1/m1. The cagA gene (31.36%) was correlated to gastric cancer (OR-3.45; 95%CI: 1.20-9.89; p = 0.02) and oipA gene (64.97%) was associated with PUD (OR = 7.87; 95% CI: 1.02–60.40; p = 0.04), homB (24.03%) with gastritis (OR-1.62; 95%CI: 1.01-2.59; p = 0.04) and ureC (59.67%) with no disease association. Therefore, our study provides genotypic prevalence of H. pylori infection in the South Indian Tamil population, with vacA s1 being the predominant genotype reported and significantly associated with gastritis and pangastritis. Hence, vacA s1 can serve as a potent virulent marker for gastrointestinal disease manifestations.
- 6 February 2026
- Published by Journal of Pure and Applied Microbiology in Journal of Pure and Applied Microbiology
- Vol. 20  (1) , 312
Open AccessExploring the Prevalence of Virulence Genes of Helicobacter pylori and their Association with Gastrointestinal Diseases in South Indian Tamils
Helicobacter pylori, a Gram-negative gastric pathogen and a class I carcinogen harbors key virulence genes such as vacA, cagA, ureC, homB and oipA that contributes to gastrointestinal diseases. The study assessed the prevalence of H. pylori infection and their correlation with virulence genotypes with clinical outcomes in South Indian Tamils. Gastric antral biopsies from 500 patients were assessed for H. pylori prevalence by RUT followed by genomic DNA extraction and PCR. Molecular confirmation employed 16S rRNA, a preliminary marker, with the identification of virulent genes cagA, vacAs1, vacA m1/m2, oipA, ureC, homB are validated by sequencing. H. pylori were confirmed in 491 patients where vacA s1 (71.89%) was correlated with gastritis (OR-1.68;95%; CI: 1.11-2.53; p = 0.013) and pangastritis (OR-4.79;95%; CI: 2.02-11.34; p = 0.0004) while vacA s1/m1 and vacA s1/m2 alleles were found to be 51.53% and 14.26%, respectively. Gastritis was associated with s1/m1 (OR-2.34; 95%CI: 1.29-4.23; p = 0.004), s1/m2 (OR-2.03; 95%CI: 1.04-3.95; p = 0.03) and pangastritis (OR-2.61;95%CI: 0.97-7.02; p = 0.05) was associated with s1/m1. The cagA gene (31.36%) was correlated to gastric cancer (OR-3.45; 95%CI: 1.20-9.89; p = 0.02) and oipA gene (64.97%) was associated with PUD (OR = 7.87; 95% CI: 1.02–60.40; p = 0.04), homB (24.03%) with gastritis (OR-1.62; 95%CI: 1.01-2.59; p = 0.04) and ureC (59.67%) with no disease association. Therefore, our study provides genotypic prevalence of H. pylori infection in the South Indian Tamil population, with vacA s1 being the predominant genotype reported and significantly associated with gastritis and pangastritis. Hence, vacA s1 can serve as a potent virulent marker for gastrointestinal disease manifestations.
- 12 January 2026
- Published by Springer Nature
- p. 343-377
Understanding the Role of miRNA Modulators in Gastrointestinal Cancers and Exploring Novel Therapeutic Capabilities
- 12 January 2026
- Published by Springer Nature
- p. 343-377
Understanding the Role of miRNA Modulators in Gastrointestinal Cancers and Exploring Novel Therapeutic Capabilities
- Open Access
- 1 January 2026
- Published by ScopeMed in Journal of Advanced Biotechnology and Experimental Therapeutics
- Vol. 9  (1) , 135-157
Deciphering the anti-cancer mechanism of ferulic acid in gastrointestinal cancers using network pharmacology, simulations, and in vitro validation
Ferulic acid (FA) was reported for its chemoprotective anticancer properties in various cancers, including lung and breast cancers. However, the exact molecular mechanism of FA targeting the JAK-STAT pathway in gastrointestinal (GI) cancers such as colon and gastric cancers, has yet to be explored. Hence, our study aims to decipher the molecular mechanism of FA by targeting the JAK-STAT pathway in GI cancers through an integrated approach of network pharmacology and molecular simulation, which would provide a new targeted therapy for GI cancers. Subsequently, various in vitro experimental validation assays, including cell proliferation assay, AO/EtBr, DAPI staining, gene and protein expression analysis, were performed on SW620 and AGS cell lines to check for the anticancer potential of FA. A total of 92 potential FA targets for GI cancer treatment were identified. Moreover, 370 entries and 72 pathways were discovered through GO and KEGG analysis. Network pharmacology data indicated that FA targets STAT3 via the JAK-STAT pathway. The molecular docking and simulations showed a high binding affinity between FA and STAT3 (-6.7 kcal/mol). Also, FA exhibited strong cytotoxic effects on GI cancer cell lines (SW620- IC50 302 µg/ ml and AGS-IC50 205 µg/ml), apoptosis validated by apoptotic staining. Further, the gene and protein expression analysis revealed the downregulation of JAK2 and STAT3 of the JAK/STAT pathway. Thus, our approach with network pharmacology and in vitro experiments has suggested that FA could be a promising drug against GI cancers.
- 1 January 2026
- Published by ScopeMed in Journal of Advanced Biotechnology and Experimental Therapeutics
- Vol. 9  (1) , 135-157
Open AccessDeciphering the anti-cancer mechanism of ferulic acid in gastrointestinal cancers using network pharmacology, simulations, and in vitro validation
Ferulic acid (FA) was reported for its chemoprotective anticancer properties in various cancers, including lung and breast cancers. However, the exact molecular mechanism of FA targeting the JAK-STAT pathway in gastrointestinal (GI) cancers such as colon and gastric cancers, has yet to be explored. Hence, our study aims to decipher the molecular mechanism of FA by targeting the JAK-STAT pathway in GI cancers through an integrated approach of network pharmacology and molecular simulation, which would provide a new targeted therapy for GI cancers. Subsequently, various in vitro experimental validation assays, including cell proliferation assay, AO/EtBr, DAPI staining, gene and protein expression analysis, were performed on SW620 and AGS cell lines to check for the anticancer potential of FA. A total of 92 potential FA targets for GI cancer treatment were identified. Moreover, 370 entries and 72 pathways were discovered through GO and KEGG analysis. Network pharmacology data indicated that FA targets STAT3 via the JAK-STAT pathway. The molecular docking and simulations showed a high binding affinity between FA and STAT3 (-6.7 kcal/mol). Also, FA exhibited strong cytotoxic effects on GI cancer cell lines (SW620- IC50 302 µg/ ml and AGS-IC50 205 µg/ml), apoptosis validated by apoptotic staining. Further, the gene and protein expression analysis revealed the downregulation of JAK2 and STAT3 of the JAK/STAT pathway. Thus, our approach with network pharmacology and in vitro experiments has suggested that FA could be a promising drug against GI cancers.
- 1 July 2025
- Published by Bentham Science Publishers Ltd. in Combinatorial Chemistry & High Throughput Screening
- Vol. 28  (7) , 1229-1239
Proteomics Approach to Identify Serum Biomarkers Associated with Gastric Cancer in South Indian Tamils
Background: Identifying cancer-specific biomarkers is a crucial step in the disease screening process at a very early stage of tumor development. In recent years, Quantitative proteomic approaches have gained importance in identifying novel candidate markers in cancer. Gastric cancer has always been known as a life-threatening medical condition with high mortality rates. Objectives: The objective of our research is to adapt serum samples from Indian gastric cancer patients to identify and understand the differentially regulated proteins in comparison with healthy individuals. Methods: A total of 30 serum isolates from gastric cancer patients and healthy individuals were obtained and subjected to 2-D Gel electrophoresis, and Tandem LC-MS analysis revealed 12 differentially expressed protein spots. The functional properties of identified proteins were further analyzed using PANTHER and STRING databases. Results: The differentially expressed protein spots were identified as three candidate proteins: Haptoglobin, Prohibitin, and Apolipoprotein. The protein interaction studies reveal that the haptoglobin fragments were upregulated, and the remaining two prohibitin and Apolipoprotein were down-regulated in gastric cancer patients. Conclusion: All the proteins identified as biomarkers were found to be involved in regulating cell proliferation and stabilization of oxidative metabolism in the liver; therefore, differential regulation plays a crucial role in gastric cancer progression.
- 1 July 2025
- Published by Bentham Science Publishers Ltd. in Combinatorial Chemistry & High Throughput Screening
- Vol. 28  (7) , 1229-1239
Proteomics Approach to Identify Serum Biomarkers Associated with Gastric Cancer in South Indian Tamils
Background: Identifying cancer-specific biomarkers is a crucial step in the disease screening process at a very early stage of tumor development. In recent years, Quantitative proteomic approaches have gained importance in identifying novel candidate markers in cancer. Gastric cancer has always been known as a life-threatening medical condition with high mortality rates. Objectives: The objective of our research is to adapt serum samples from Indian gastric cancer patients to identify and understand the differentially regulated proteins in comparison with healthy individuals. Methods: A total of 30 serum isolates from gastric cancer patients and healthy individuals were obtained and subjected to 2-D Gel electrophoresis, and Tandem LC-MS analysis revealed 12 differentially expressed protein spots. The functional properties of identified proteins were further analyzed using PANTHER and STRING databases. Results: The differentially expressed protein spots were identified as three candidate proteins: Haptoglobin, Prohibitin, and Apolipoprotein. The protein interaction studies reveal that the haptoglobin fragments were upregulated, and the remaining two prohibitin and Apolipoprotein were down-regulated in gastric cancer patients. Conclusion: All the proteins identified as biomarkers were found to be involved in regulating cell proliferation and stabilization of oxidative metabolism in the liver; therefore, differential regulation plays a crucial role in gastric cancer progression.
- 1 November 2024
- Published by Bentham Science Publishers Ltd. in Current Cancer Therapy Reviews
- Vol. 20  (6) , 523-528
Childhood Heart Tumors: Detection, Diagnosis, and Treatments
: Childhood cardiac tumors are rare but challenging conditions that can have a significant impact on a child’s health and even be fatal if not detected and diagnosed timely. While various types of tumors can occur in the heart, the most common among children are benign tumors, such as rhabdomyomas. Diagnosis of pediatric cardiac tumors is often challenging and requires a combination of clinical examination, imaging studies and biopsy. In some cases, the tumors may be asymptomatic and discovered incidentally, while in others, they can cause symptoms, such as shortness of breath, chest pain, arrhythmias and congestive heart failure. Treatment options for pediatric cardiac tumors vary depending on the type, size and location of the tumor and may include surgical resection, watchful waiting or a combination of both. The prognosis for children with cardiac tumors is generally good, with a high rate of complete cure in many cases. However, long-term follow-up and monitoring are important to detect and manage any potential complications or recurrence of the tumors.
- 1 November 2024
- Published by Bentham Science Publishers Ltd. in Current Cancer Therapy Reviews
- Vol. 20  (6) , 523-528
Childhood Heart Tumors: Detection, Diagnosis, and Treatments
: Childhood cardiac tumors are rare but challenging conditions that can have a significant impact on a child’s health and even be fatal if not detected and diagnosed timely. While various types of tumors can occur in the heart, the most common among children are benign tumors, such as rhabdomyomas. Diagnosis of pediatric cardiac tumors is often challenging and requires a combination of clinical examination, imaging studies and biopsy. In some cases, the tumors may be asymptomatic and discovered incidentally, while in others, they can cause symptoms, such as shortness of breath, chest pain, arrhythmias and congestive heart failure. Treatment options for pediatric cardiac tumors vary depending on the type, size and location of the tumor and may include surgical resection, watchful waiting or a combination of both. The prognosis for children with cardiac tumors is generally good, with a high rate of complete cure in many cases. However, long-term follow-up and monitoring are important to detect and manage any potential complications or recurrence of the tumors.
- Open Access
- 14 August 2024
- Published by Journal of Pure and Applied Microbiology in Journal of Pure and Applied Microbiology
- Vol. 18  (3) , 1786-1798
Association of a NLRP3 rs10754558 Polymorphism with the Development of Chronic Helicobacter pylori Infection in South Indian Tamils
The increased prevalence of Helicobacter pylori infection and inadequate genetic research on the same, demands a genetic study among Tamil population of South India to unravel the association of NLRP3 (NLR family pyrin domain containing 3) variants with persistent H. pylori infection. This research was aimed to study the correlation between persistent H. pylori infection and influence of such genetic variants in the development of disease progression. In this study, 200 healthy volunteers and 120 H. pylori-positive cases were screened for two NLRP3 variants, rs74163773 and rs10754558, using allele-specific PCR and TaqManTM SNP genotyping assay, respectively. Based on our genotype and allelic distribution, rs74163773 variant did not associate with the risk of developing the persistent infection. However, a significant association of heterozygous CG variant of rs10754558 with patient showing clinical symptoms of gastritis, PUD and persistent infection in the over-dominant, co-dominant and recessive models was found. Our findings suggest that persistent H. pylori infection susceptibility was influenced by genetic variant rs10754558 and its heterozygous CG variant can serve as an independent risk factor in the manifestation of chronic gastritis and PUD in the South Indian Tamils.
- 14 August 2024
- Published by Journal of Pure and Applied Microbiology in Journal of Pure and Applied Microbiology
- Vol. 18  (3) , 1786-1798
Open AccessAssociation of a NLRP3 rs10754558 Polymorphism with the Development of Chronic Helicobacter pylori Infection in South Indian Tamils
The increased prevalence of Helicobacter pylori infection and inadequate genetic research on the same, demands a genetic study among Tamil population of South India to unravel the association of NLRP3 (NLR family pyrin domain containing 3) variants with persistent H. pylori infection. This research was aimed to study the correlation between persistent H. pylori infection and influence of such genetic variants in the development of disease progression. In this study, 200 healthy volunteers and 120 H. pylori-positive cases were screened for two NLRP3 variants, rs74163773 and rs10754558, using allele-specific PCR and TaqManTM SNP genotyping assay, respectively. Based on our genotype and allelic distribution, rs74163773 variant did not associate with the risk of developing the persistent infection. However, a significant association of heterozygous CG variant of rs10754558 with patient showing clinical symptoms of gastritis, PUD and persistent infection in the over-dominant, co-dominant and recessive models was found. Our findings suggest that persistent H. pylori infection susceptibility was influenced by genetic variant rs10754558 and its heterozygous CG variant can serve as an independent risk factor in the manifestation of chronic gastritis and PUD in the South Indian Tamils.
- 8 May 2024
- Published by Springer Nature
- p. 221-250
Current Insights into the Potential of Gene Therapy to Treat Rare Mitochondrial Diseases
- 8 May 2024
- Published by Springer Nature
- p. 221-250
Current Insights into the Potential of Gene Therapy to Treat Rare Mitochondrial Diseases